MAR 30, 2017 10:45 AM PDT

Newly Identified Risk Loci for Gliomas

WRITTEN BY: Xuan Pham

A new research into the causes of deadly brain cancer implicates 13 new genetic regions. This doubles the number of known genetic mutations that seem to increase the risk for glioma – one of the most common forms of brain cancer.

The study was an international collaboration with researchers from Europe, the United Kingdom, and the United States. The meta-analysis included data on nearly 12,500 patients with gliomas, and over 18,000 healthy individuals.

The large sample size allowed the researchers to more precisely identify genetic susceptibility regions with a genetic tool known as a genome-wide association study (GWAS). With this analysis, they found 5 new genetic regions that increase the risk for a deadly form of glioma known as glioblastoma multiforme (GBM). They also found 8 new regions that are associated with increased risk of non-GBM tumors – a less lethal glioma type.

The genetic regions implicated in this study are linked to cell division, cell cycle regulation, neurogenesis, and regulation of some key proteins.

"The changes in the way we think about glioma could be quite fundamental," said Richard Houston, the study’s co-senior author. "So for example, what we thought of as two related subtypes of the disease turn out to have quite different genetic causes which may require different approaches to treatment."

Of note, gliomas make up about 27 percent of all brain cancers, which result in 13,000 deaths every year. In particular, the GBM form of glioma is particularly aggressive and notorious for the dismally grim 5-year survival rate of less than 10 percent.

"It has been exciting to have been involved in such a gigantic study including cases of brain cancer from all over the world. We have uncovered a treasure trove of new information about the genetic causes of glioma brain cancers,” said Houlston. “Understanding the genetics of glioma in such detail allows us to start thinking about ways of identifying people at high inherited risk, and will open up a search for new treatments that exploit our new knowledge of the biology of the disease."

Additional sources: MNT

About the Author
  • I am a human geneticist, passionate about telling stories to make science more engaging and approachable. Find more of my writing at the Hopkins BioMedical Odyssey blog and at TheGeneTwist.com.
You May Also Like
SEP 11, 2020
Cancer
Taking cancer treatment from a whole new angle
SEP 11, 2020
Taking cancer treatment from a whole new angle
New cancer research is looking at treatment for the disease from an entirely new angle: structurally. While chemotherapy ...
SEP 12, 2020
Cancer
Treating cancer with the botanical andrographis
SEP 12, 2020
Treating cancer with the botanical andrographis
A study from City of Hope published in the journal Carcinogenesis reports that the use of the natural botanical And ...
SEP 17, 2020
Cardiology
Can Grape Polyphenol Extracts prevent Cardiotoxicity?
SEP 17, 2020
Can Grape Polyphenol Extracts prevent Cardiotoxicity?
One of the biggest issues with chemotherapy treatments is their inherent toxicities. Most chemotherapy drugs are toxic t ...
SEP 21, 2020
Cancer
The Protein ETV1 May Act as a Biomarker for Gastrointestinal Cancer
SEP 21, 2020
The Protein ETV1 May Act as a Biomarker for Gastrointestinal Cancer
Cancer is an incredibly diverse disease. It has many types and even sub-types, with a vast range of characteristics. Som ...
SEP 30, 2020
Cancer
How to avoid endocrine disrupting chemicals in your life
SEP 30, 2020
How to avoid endocrine disrupting chemicals in your life
While few people actually enjoy reading product labels and ingredients, a new study from Silent Spring Institute suggest ...
NOV 14, 2020
Cancer
New intravenous anti-cancer therapy crosses blood-brain barrier
NOV 14, 2020
New intravenous anti-cancer therapy crosses blood-brain barrier
New research from the University of Michigan reports for the first time a new synthetic protein nanoparticle that is abl ...
Loading Comments...